Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge

Autor:	Brady S. Moffett, Shelly Kim, Lisa Bomgaars
Rok vydání:	2013
Předmět:	medicine.medical_specialty Multivariate analysis business.industry medicine.medical_treatment Mitral valve replacement Warfarin Lansoprazole Hematology Surgery Fontan procedure Oncology Levofloxacin Pediatrics Perinatology and Child Health medicine Escitalopram Adverse effect business medicine.drug
Zdroj:	Pediatric Blood & Cancer. 60:1503-1506
ISSN:	1545-5009
DOI:	10.1002/pbc.24546
Popis:	Background Warfarin therapy in pediatric patients can be difficult to manage with bleeding as a primary adverse event. Therapy initiation can be difficult as doses to achieve therapeutic outcomes are being determined. Evaluation of readmission for bleeding in pediatric patients discharged on warfarin therapy may be useful to prevent adverse events. Methods The Pediatric Health Information System (PHIS) was queried to identify all patients
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::571d7e8511e2f76c50c7c2d6d97cd094 https://doi.org/10.1002/pbc.24546 Zobrazit plný text záznamu Plný text